SCP-1841
Safe
~
medium confidence
SCP-1841
Expected annual
$410K
One-time setup
$34K
Annual recurring
$396K
Personnel
2.5
One-time setup costs are modest (~$34,000) for containment, archival housing and imaging; the primary recurring expense is staff wages and research/monitoring, driving an annual baseline of ~$396k, with contingency and sporadic incident/legal costs raising expected annual outlays.
One-Time Capital Costs
Total: $34K
Annual Recurring Costs
Total: $396K/yr
Cost Scenarios
📊
Baseline
(baseline)
$396K/yr
Normal year with low use: routine monitoring, occasional controlled activations, and standard overhead.
low-use activations
routine monitoring
scheduled research tasks
🚨
Minor Incident
$403K/yr
Subject attempts an unsanctioned trip or requires clinician intervention; field team and extra monitoring deployed.
unsanctioned travel attempt
one-off clinician intervention
short field deployment
🚨
Major Public Exposure
$596K/yr
Public incident with multiple civilian witnesses, media attention, lawsuits or large-scale recovery operation requiring extensive legal/PR and amnestic operations.
public discovery
media coverage
multi-witness exposures
🚨
Research Scale Up
$516K/yr
Foundation elects to run an intensive research program (neuroimaging, longitudinal studies, expanded clinical trials).
fMRI/neuroimaging studies
expanded longitudinal trials
multi-subject controlled activations
Personnel
2.5 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist (Lead) | 1 | [#5] Full-time research lead responsible for access requests, experiments, ethics compliance and reporting (budgeted at ~$150,000/yr). |
| Research Assistant | 1 | [#5] One part-time/fee-for-service research assistant (~$60,000/yr equivalent budgeted). |
| Security Officer / MTF Agent | 0.5 | [#4] ~0.5 FTE guard increment for access control and audits (budgeted at ~$40,000/yr). |
Confidence Notes
Line-item price ranges are supplied in analyst notes and containment is straightforward (Safe), so structural and equipment costs are well-defined; uncertainty remains around activation frequency, clinical escalation rates, and the probability of public-exposure events, so annual incident-related costs and probabilities are moderate-confidence estimates.